0000904454-23-000031.txt : 20230120 0000904454-23-000031.hdr.sgml : 20230120 20230120155730 ACCESSION NUMBER: 0000904454-23-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230118 FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Soteropoulos Paula CENTRAL INDEX KEY: 0001692444 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 23540897 MAIL ADDRESS: STREET 1: 49 WINONA STREET CITY: PEABODY STATE: MA ZIP: 01960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2023-01-18 0 0001590560 uniQure N.V. QURE 0001692444 Soteropoulos Paula C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 11058BP NETHERLANDS 1 0 0 0 Ordinary Shares 2023-01-18 4 M 0 6000 5.37 A 22382 D Ordinary Shares 2023-01-18 4 S 0 6000 22.59 D 16382 D Stock Option (Right to Buy) 5.37 2023-01-18 4 M 0 6000 0 D 2018-01-27 2027-01-27 Ordinary Shares 6000 2000 D The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. /s/ Christian Klemt, Attorney-in-Fact 2023-01-20